NeuroVision Imaging, LLC

6 articles about NeuroVision Imaging, LLC

• NeuroVision Imaging Inc. Announces Additional Funding From the ADDF to Accelerate Development of Novel Blood-Based Lab Test to Predict Dementia Before Clinical Onset

  8/24/2021

  NeuroVision Imaging Inc. announced it has received an additional investment from the Alzheimer’s Drug Discovery Foundation – the foundation’s second round of funding to NeuroVision this year – to hasten development of a novel blood-based lab test to provide detection and measurement of biomarkers for Alzheimer’s disease and other dementias before clinical onset.

• Alzheimer’s Therapeutics Research Leader Dr. Roy Twyman Joins NeuroVision Imaging Board

  7/18/2018

  Twyman Served as Senior Vice President at Janssen Pharmaceutical Research & Development, Overseeing Alzheimer’s Disease Therapeutics.

• NeuroVision Announces a $15 Million Series C Financing With a First Close of $11.2 Million

  5/2/2018

  NeuroVision Imaging Inc. has announced a Series C financing round of $15 million with an initial close of $11.2 million.

• NeuroVision Imaging Release: Clinical Study Shows That Retinal Imaging May Detect Signs Of Alzheimer’s Disease

  8/22/2017

• NeuroVision Imaging Announces Participation In Landmark Alzheimer’s A4 Study Evaluating Its Novel Retinal Imaging Technology

  2/28/2017

• NeuroVision Imaging Announces $10 Million Series B Financing

  6/29/2016